Tag Archives: Biotechnology

Monsanto's Rat Tumor Scare: A Wake-Up Call for the Pharma Industry?

ARE Monsanto’s RAT-TUMOUR SCARES A WAKE-UP CALL TO THE PHARMA INDUSTRY? By Reflector, Brussels correspondent. The furore that burst across Brussels in late September over reported findings of tumors in rats fed with genetically modified maize may seem only tangentially related to the concerns of European pharmaceutical executives — but the significance of the debate […]
Posted in Biotech, Europe, Gene therapy, Guest Blog, Op-Ed, Safety, Technology | Also tagged , , , , , | 2 Comments

The JOBS Act: A Boost for Biopharma?

Amid one of the most divisive eras in our nation’s political history, one thing we can all pretty much agree on is the fact that our stalled economic engine needs a jumpstart. According to recent data from the US Bureau of Labor Statistics, the national unemployment rate has been above 8% for more than three […]
Posted in Biotech, Guest Blog | Also tagged , | Leave a comment

Florida Builds on Biotech Industry

While the biotechnology industry has weakened across the U.S., Florida has seen a 21 percent jump in the number of biotech companies since 2008 and a surge in investment, according to the University of Florida. Updated numbers from the Florida BioDatabase, maintained by the University of Florida’s Sid Martin Biotechnology Incubator. in Alachua, show 29 […]
Posted in Biotech | Also tagged , | Leave a comment

California Biotech — Good Governance Tops Wish List

New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared work force complacent about hungry foreign competition. California’s biotech industry has taken its annual pulse of business conditions — and while the prognosis is not for putting the state on the policy equivalent of […]
Posted in Biotech, FDA, healthcare, R&D, Strategy | Also tagged , , , , | Leave a comment

Fixing Biotech's Broken Business Model

Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has […]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta